Related Experiment Video
Updated: Apr 19, 2026

Assessment of Child Anthropometry in a Large Epidemiologic Study
Published on: February 2, 2017
[Obesity and cardiovascular risk in children]
Insights
Childhood obesity is rising globally, leading to early heart disease risks even in preschoolers. Early intervention and multidisciplinary strategies are crucial for prevention and managing associated health issues.
Area of Science:
- Pediatric Endocrinology
- Cardiovascular Health
- Metabolic Disorders
Context:
- Childhood obesity rates have surged globally, with onset at younger ages.
- Obesity is linked to serious complications and cardiovascular risk factors from early childhood.
- Cardiometabolic risks, including fatty liver, appear early in overweight/obese preschoolers.
Purpose:
- To highlight the early onset of cardiometabolic risk factors in childhood obesity.
- To emphasize the need for early prevention and screening of comorbidities.
- To underscore the importance of multidisciplinary approaches in pediatric obesity management.
Summary:
- The ORIGIN study detected cardiometabolic risks like fatty liver in preschoolers with overweight/obesity.
- These risks were present despite short-term excess weight exposure and reduced insulin sensitivity.
- Early cardiometabolic impairments are reversible with lifestyle interventions in children.
Impact:
- Early detection and intervention are vital for preventing long-term health consequences of childhood obesity.
- Multidisciplinary strategies are essential for effective childhood obesity prevention and comorbidity screening.
- Findings support proactive public health initiatives targeting pediatric weight management and metabolic health.
Abstract:
Prevalence of overweight and obesity in childhood has substantially increased worldwide in recent decades with children becoming obese at progressively younger ages. Obesity in children carries a wide range of serious complications, and contributes to an increased prevalence of cardiovascular risk factors such as hypertension, hypertrygliceridema, low high-density lipoprotein cholesterol (HDL), impaired glucose metabolism and early atherosclerotic changes not only in adulthood but since in very early pediatric age. In the ORIGIN study (Outcome Reduction with an Initial Glargine Intervention), cardiometabolic risk factors including fatty liver were already detectable in preschoolers at the onset of overweight/obesity despite short-term exposure to excess weight and fairly reduced insulin sensitivity. These facts together with the evidence that early cardiometabolic impairment reverts with lifestyle intervention in pediatric age, emphasize the need to start prevention of childhood obesity and screening of cardiometabolic co-morbities at the earliest stage with multidisciplinary strategies.
Related Concept Videos
Obesity
Coronary Artery Disease I: Introduction
Drug Dosing: Obese Patients
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...

